Prevalence of Ocular Surface Disease in Malaysian Glaucoma Patients

NCT04609345 · Status: UNKNOWN · Type: OBSERVATIONAL · Enrollment: 400

Last updated 2020-10-30

No results posted yet for this study

Summary

This is a prospective, multi-centre, cross sectional observational study to determine the prevalence of ocular surface disease (OSD) in glaucoma patients, nationwide. The study also analyses sub group of OSD prevalence, stratified according to the treatment types (i.e. preserved, preservative-free, and combination of preservative-free and preserved eyedrops), and illustrates the patient perspective on OSD.

Conditions

  • Primary Open-angle Glaucoma
  • Primary Angle-Closure Glaucoma
  • Pseudoexfoliation Glaucoma
  • Pigment Dispersion Glaucoma
  • Ocular Hypertension

Sponsors & Collaborators

  • Santen Pharma Malaysia Sdn Bhd

    lead INDUSTRY

Principal Investigators

  • Eng Hui Gan, Specialist · International Specialist Eye Centre (ISEC)

Eligibility

Min Age
21 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2020-11-30
Primary Completion
2021-04-30
Completion
2021-05-31

More Related Trials

Entities

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT04609345 on ClinicalTrials.gov